What medical device OEMs and hospital IT teams need to think about when specifying screen protectors — FDA position, IEC 60601, sterilisation and audit documentation.
Screen protectors on medical devices occupy a genuinely tricky regulatory position. They aren't medical devices themselves in most jurisdictions — they're consumable accessories. But they sit on the user-touched surface of a medical device, which means they affect cleanability, ingress protection, optical properties and patient-facing surfaces. That's enough to bring them into the regulatory conversation, even if not into formal device classification.
This article walks through what medical device OEMs and hospital IT teams need to think about when specifying screen protectors. It's not legal advice — your regulatory affairs team owns the final word — but it's the framing that should inform what you put on the RFQ.
The US Food and Drug Administration regulates medical devices, not most accessories used with them. A screen protector applied to a hospital tablet is not, in itself, a Class I, II or III medical device. The FDA's view tends to be that the accessory inherits the classification of the device it's used with only if it materially affects the device's intended use or safety profile.
For most clinical tablets, EHR workstations, infusion pump displays and similar devices, a properly-specified screen protector does not change the device's regulatory status. It doesn't interact with the patient in a regulated way, it doesn't deliver therapy, and it doesn't process patient data.
Where it can matter is when the screen protector affects properties the original device manufacturer relied on for clearance — particularly optical clarity for imaging displays, electrical isolation in some scenarios, or ingress protection ratings. If your device was cleared on the basis of specific surface properties, changing those properties via an aftermarket protector is a question worth running past your regulatory team.
IEC 60601 is the family of international standards for medical electrical equipment safety and essential performance. It covers electrical safety, mechanical hazards, electromagnetic compatibility, and a long list of usability and environmental considerations.
Screen protectors intersect IEC 60601 in a few specific places:
Medical devices in clinical environments are wiped down repeatedly with isopropyl alcohol, quaternary ammonium compounds, hydrogen peroxide solutions and sometimes bleach. The protector's adhesive layer and top coating both need to survive this. PET films with cheap acrylic adhesives can yellow, lift at the edges, or develop cloudy patches after a few months of IPA wipe-down. Properly-specified medical protectors use IPA-resistant adhesive chemistries and top coats designed for repeated disinfection.
If the underlying device has an IP rating (resistance to dust and liquid ingress), the protector application must not compromise it. This usually means edge-to-edge bonding without gaps, or a protector cut to sit inside the device bezel rather than overlapping it. Specifying this correctly at design stage avoids a surprise at audit.
For devices where the display is part of the diagnostic or clinical decision-making process — ultrasound, ophthalmology, dermatoscopy — the protector affects what the clinician sees. Light transmission, haze and colour accuracy all matter. For these applications, glass is usually preferred over film due to better optical performance, and a higher-grade glass specification (low-iron glass, anti-reflective coating) may be justified.
Rarely a concern for screen protectors, but worth noting: some specialty protectors include conductive or metallic layers (touch-shielding for example) which can affect EMC performance. Standard glass and PET protectors are electrically inert and don't typically introduce EMC issues.
Many medical device protectors are specified with antimicrobial surface treatments. The relevant standards are:
Antimicrobial protectors typically use silver-ion or copper-ion additives in the surface coating. They reduce — but don't eliminate — surface bacterial load between cleaning cycles. They are not a substitute for proper disinfection protocols, and any supplier claiming otherwise is overselling.
When specifying antimicrobial properties, ask for the specific ISO 22196 test report (with the test organism, test duration and log reduction figure). "Antimicrobial" without a test report is marketing language with no enforceable meaning.
Privacy filters — the micro-louvre layers that restrict viewing angle — are a legitimate technical control for HIPAA (US) and GDPR (EU) compliance on devices displaying patient data in spaces where unauthorised viewing is possible. They don't replace administrative and technical controls, but they're a recognised physical layer in defence-in-depth thinking.
When specifying privacy protection on medical devices, the relevant decisions are:
For any screen protector going onto a medical device, the supplier should provide:
A supplier who can't produce this documentation as a standard pack — rather than scrambling to put it together — is not a supplier with a healthcare track record.
Before specifying material, treatment or finish, ask: what does the device's regulatory and audit position require? The answer often constrains the protector specification more than any engineering preference would. Devices cleared with specific surface properties need protectors that don't change those properties. Devices in environments with specific disinfection protocols need protectors that survive those protocols. Devices in spaces with patient data visibility need privacy considerations built in.
Get the regulatory and infection-control framing right first. The material choice follows.
Send a brief and we'll respond within 24 working hours with a quote you can compare cleanly against other responses.
Email hello@customscreenprotectors.com →